Before that, in late 2022, Fresenius Kabi earned yet another Class I tag for a recall of its then-newly acquired infusion system. That recall specifically concerned the pump’s software, as the ...

Less than a year after putting down $240 million to acquire of Ivenix and its sensor- and software-backed infusion pump, Fresenius Kabi is recalling more than 1,500 of them. The recall affects ...

Fresenius Kabi warned healthcare providers in a Dec. 5 letter to stop using certain Ivenix large-volume pumps because of the risk that pneumatic valves installed in some devices could issue a pump ...

The early alert on Fresenius' device is part of a new pilot by the FDA to improve the timeliness around public communications over potentially high-risk device recalls. Image credit: Tada Images ...

Fresenius Kabi has added a fentanyl product to its range of ready-to-administer prefilled syringe. The 1-mL presentation, which Fresenius said is unique on the U.S. market, is designed to cut ...

The U.S. FDA has announced a class I recall of Iveninx large-volume infusion pumps made by Fresenius Kabi USA of Lake Zurich, Ill., due to a mechanical issue with fluid valve pins that could cause the ...

BOSTON--(BUSINESS WIRE)--Ivenix, Inc. today announced that it has entered into a definitive agreement to be acquired by Fresenius Kabi ... s most advanced infusion pump technology with the ...

Fresenius Kabi offers U.S. customers a broad range of Heparin presentations which now includes the Heparin 5,000 USP units per mL ready-to-administer prefilled syringe for subcutaneous and ...

Fresenius Kabi ... prefilled syringe and a self-administered pre-filled pen (autoinjector) in July 2023. “This is another important milestone for Fresenius Kabi in fulfilling our strategic ...